Project Approval Process Sample Clauses

Project Approval Process. The Parties shall define each new Joint Project by implementing a signed SOW, substantially in the form of the statement of work set forth in this Exhibit, setting forth the appropriate work items for carrying out each respective Joint Project. All Projects which involve the operation of CNSE Tools, including Manufacturing Equipment, by FOUNDATION Personnel will also require a signed SOW setting forth the appropriate work items for carrying out each respective Joint Project. Each SOW shall include a start date, a Joint Project Target End Date, a Joint Project description, target process development objectives, milestones, the expected roles of the Parties, and the scope of work, with all dates and time periods in each SOW being targets only. The Program Managers shall be responsible for coordinating communications and execution of actions toward achievement of the milestones. Each Party will use commercially reasonable efforts for the successful completion of milestones. The Parties may from time to time, as new SOWs are developed within the budget, amend Exhibit D to add such SOWs as necessary. Upon written acceptance by the Parties, such additional SOWs will become part of this Agreement and attached in this Exhibit. Failure however to formally amend this Exhibit has no bearing on the agreed Joint Project SOW becoming part of the Program and part of this Agreement.
AutoNDA by SimpleDocs
Project Approval Process. The Parties are under no obligation to initiate any projects. However, once the Parties have agreement, in writing, to proceed in accordance with an associated Project Plan ("Project Acceptance"), such project shall be deemed a Project and shall proceed accordingly. If ST rejects a Project Plan initiated by Apogee, Apogee shall be allowed to utilize ST manufacturing services and resources,and ST shall provide such resources and services, to produce finished die, provided that the Parties have an agreement on prices and commercial terms and conditions to be negotiated between the Parties, in good faith and on a case by case basis. No discussions shall become a "Project" nor a binding obligation on either Party, until and unless the Parties have agreement, in writing, to proceed in accordance with an associated Project Plan.
Project Approval Process. (a) At any time during the year, the president may propose or cause to be proposed to the Board of Directors that the Company undertake research and development, marketing or other activities that are within the scope of the Approved Business. Any such proposal may also be included in the proposed Budget for the Company's subsequent year. All such proposals shall be in the format required by the Board of Directors. An example of such format, approved by the Board of Directors, is attached hereto as Exhibit B. Any such proposal shall set forth the material terms and conditions of the proposed project, including, without limitation, the estimated capital expenditures and other estimated expenses of the project, capital contribution requirements for the project, income and cash flow projections, whether the project is anticipated to require any arrangements or agreements pursuant to the Preferred Supplier provisions of Section 14.3 hereof, a competitive market analysis of the results of the project, an evaluation of the technical feasibility of the proposed project, an evaluation of possible intellectual property bars, an evaluation of environmental, health and safety risks, a high level research plan, and the number of personnel anticipated to be required to staff the project (and, if any new personnel are required, the number and type of personnel so required).
Project Approval Process. Following a recommendation of funding and the receipt of project information from the Service Manager through GOS, a project that is approved will receive a Conditional Letter of Commitment (CLC) from the Ministry, which confirms Ministry approval and outlines the steps to take prior to signing a Contribution Agreement (CA). The CA shall describe legal obligations and reporting requirements for the project. SMs are required to enter into CAs directly with proponents. As funding allocations must be committed for each year of the program, the deadline to execute CAs is January 31st of each program year to allow time for re-allocation of funds if necessary. SMs that have not signed a CA or have not begun construction by the required dates may have their funding re-allocated.
Project Approval Process. (A) Public Facilities Approval. Following TAC approval of the Master Development Plan and plat, if required by Broward County, and prior to applying for any building permits for the construction of the Public Facilities of the Project, Developer shall obtain City’s written approval (or by the Deemed Approval Process) pursuant to the procedures set forth in this Section. Upon developing its building plans and specifications for the Public Facilities to the 50% design level (“Schematic Drawings”), Developer shall submit the same to City for its review and approval, which shall be approved in writing by the City or deemed approved pursuant to the Deemed Approval Process, provided that City acknowledges that its right to object or request changes to the Schematic Drawings is limited to an observed basis for determining that the Schematic Drawings (a) constitute a Material Design Change to the Master Development Plan previously approved or deemed approved by City or (b) are not compliant with this Agreement or applicable laws. If City submits timely objections to the Schematic Drawings in accordance with this provision, Developer shall either (x) resubmit the revised Schematic Drawings for City’s approval pursuant to the same standards and procedures as the original Schematic Drawings, provided that City shall grant or deny approval within eight Business Days of City’s receipt of the revised Schematic Drawings, or (y) request review by the Orangebrook Review Board pursuant to Section 5.4 of this Agreement. After the Schematic Drawings have been approved, Developer shall develop its building plans and specifications for the Public Facilities to the 100% design level (“Construction Drawings”) and submit the same to City for its approval, which shall be approved in writing by the City or deemed approved pursuant to the Deemed Approval Process; provided, however, that City acknowledges that its right to object or request changes to the Construction Drawings in its proprietary capacity is limited to an observed basis for determining that the Construction Drawings (i) constitute a Material Design Change to the Schematic Drawings previously approved or deemed approved by City or (ii) are not compliant with this Agreement or applicable laws. If City submits timely objections to the Construction Drawings in accordance with this provision, Developer shall either (A) resubmit the revised Construction Drawings for City’s approval pursuant to the same standards and procedur...
Project Approval Process. Project approval will be based on an alignment with the approved Investment Plan, consideration of the information submitted to MMAH and the ability to meet the program’s eligibility criteria. Once approved, a project will receive a Conditional Letter of Commitment from MMAH, which confirms MMAH approval and outlines the steps to take prior to signing a Contribution Agreement. The Contribution Agreement shall describe legal obligations and reporting requirements for the project. All SMs are required to enter into Contribution Agreements directly with proponents and shall require the forgivable loan to be secured through a mortgage or alternate form of security. The deadline to commit funding – i.e., execute Contribution Agreements and submit executed Agreements of Purchase and Sale (for acquisition projects), registration of mortgage security or an alternate form of security (for modular housing projects) – will be November 30, 2022, to allow time for reprofiling between operating and capital funding, or reallocation of funds if necessary. MMAH reserves the right to return a project application for revision and resubmission if it is not consistent with these Program Guidelines.
Project Approval Process a. As a condition to City staff determining whether to forward a Parcel development proposal to the City Council for consideration, Developer shall prepare and produce for City staff’s review prior to the applicable Project Proposal milestone date identified in Section 6 above for each Parcel the following (each, collectively, a “Project Proposal”):
AutoNDA by SimpleDocs
Project Approval Process. 4. No project is eligible for cost-sharing under this Agreement unless it has been approved by both parties to this Agreement prior to the commencement of the project. The parties agree that the joint approval process will be as follows. Once Alberta approves a project, it will forward a recommendation for approval of the project to the Federal Minister using the Project Recommendation Form attached as Schedule C and providing the information specified on the Form. Upon receipt of the recommendation, the Federal Minister will promptly review it and notify Alberta of the Federal Minister's approval of the project if satisfied that the project meets the requirements of the Target Initiative for Older Workers Program.
Project Approval Process 

Related to Project Approval Process

  • Project Completion Part 1 – Material Completion

  • Development Work The Support Standards do not include development work either (i) on software not licensed from CentralSquare or (ii) development work for enhancements or features that are outside the documented functionality of the Solutions, except such work as may be specifically purchased and outlined in Exhibit 1. CentralSquare retains all Intellectual Property Rights in development work performed and Customer may request consulting and development work from CentralSquare as a separate billable service.

  • Project Plan Development of Project Plan Upon the Authorized User’s request, the Contractor must develop a Project Plan. This Project Plan may include Implementation personnel, installation timeframes, escalation procedures and an acceptance plan as appropriate for the Services requested. Specific requirements of the plan will be defined in the RFQ. In response to the RFQ, the Contractor must agree to furnish all labor and supervision necessary to successfully perform Services procured from this Lot. Project Plan Document The Contractor will provide to the Authorized User, a Project Plan that may contain the following items: • Name of the Project Manager, Contact Phone Numbers and E-Mail Address; • Names of the Project Team Members, Contact Phone Numbers and E-Mail Address; • A list of Implementation milestones based on the Authorized User’s desired installation date; • A list of responsibilities of the Authorized User during system Implementation; • A list of designated Contractor Authorized Personnel; • Escalation procedures including management personnel contact numbers; • Full and complete documentation of all Implementation work; • Samples of knowledge transfer documentation; and • When applicable, a list of all materials and supplies required to complete the Implementation described in the RFQ. Materials and Supplies Required to Complete Implementation In the event that there are items required to complete an Implementation, the Contractor may request the items be added to its Contract if the items meet the scope of the Contract. Negotiation of Final Project Plan If the Authorized User chooses to require a full Project Plan, the State further reserves the right for Authorized Users to negotiate the final Project Plan with the apparent RFQ awardee. Such negotiation must not substantively change the scope of the RFQ plan, but can alter timeframes or other incidental factors of the final Project Plan. The Authorized User will provide the Contractor a minimum of five (5) business days’ notice of the final negotiation date. The Authorized User reserves the right to move to the next responsible and responsive bidder if Contractor negotiations are unsuccessful.

  • Production Work The Company may use Outside Entities to perform production work outside the plant and its environs provided the Company demonstrates that it is utilizing plant equipment to the maximum extent consistent with equipment capability and customer requirements and the Company is making necessary capital investments to remain competitive in the steel business and is in compliance with Article Eleven, Section B (Investment Commitment).

  • Required Regulatory Approvals Certain transactions required, permitted or otherwise contemplated by this Agreement may under certain circumstances require prior filings with and approvals, or non-disapprovals, from the Indiana Department of Insurance or the Indiana Insurance Commissioner. Such transactions include: (a) issuance or purchase of any additional capital stock of the Company or other securities convertible into or exchangeable or exercisable for capital stock of the Company pursuant to Sections 1.2 or 3.4; (b) transfer of Shares to a wholly owned subsidiary of a Shareholder, to another Shareholder or to a wholly owned subsidiary of another Shareholder pursuant to Sections 3.1(a) or 3.4; (c) exercise of preemptive rights by a Shareholder pursuant to Section 3.2; and (d) exercise of call rights by the Company or a Shareholder pursuant to Section 3.3 (including pursuant to the two provisos in Section 3.1(b)). Notwithstanding anything to the contrary contained in this Agreement, any such transactions requiring filings with and approvals, or non-disapprovals, from the Indiana Department of Insurance or the Indiana Insurance Commissioner shall not, to the extent within the control of a party hereto, be entered into or consummated unless and until the required filings have been made and the required approvals (or non-disapprovals) have been obtained, and to the extent not within the control of an applicable party hereto, such party shall use best efforts to cause such transactions not to be entered into or consummated unless and until the required filings have been made and the required approvals (or non-disapprovals) have been obtained.

  • Development and Regulatory Milestones With respect to each of the following milestones, Ikaria shall pay BioLineRx the corresponding payment set forth below within [**] days after the achievement by Ikaria, its Affiliates or Licensees of such milestone: MILESTONE PAYMENT

  • Requisite Regulatory Approvals All Consents required to be obtained from or made with any Governmental Authority in order to consummate the transactions contemplated by this Agreement shall have been obtained or made.

  • Information Systems Acquisition Development and Maintenance Security of System Files. To protect City Information Processing Systems and system files containing information, Service Provider will ensure that access to source code is restricted to authorized users whose specific job function necessitates such access.

  • Site Visits and Inspections; Regulatory Examinations During the term of this Agreement, authorized representatives of the Fund may conduct periodic site visits of the Transfer Agent’s facilities and inspect the Transfer Agent’s records and procedures solely as they pertain to the Transfer Agent’s services for the Fund under or pursuant to this Agreement. Such inspections shall be conducted at the Fund’s expense (which shall include costs related to providing materials, copying, faxing, retrieving stored materials, and similar expenses) and shall occur during the Transfer Agent’s regular business hours and, except as otherwise agreed to by the parties, no more frequently than twice a year. In connection with such site visit and/or inspection, the Fund shall not attempt to access, nor will it review, the records of any other clients of the Transfer Agent and the Fund shall conduct the visit/inspection in a manner that will not interfere with the Transfer Agent’s normal and customary conduct of its business activities, including the provision of services to the Fund and to other clients. The Transfer Agent shall have the right to immediately require the removal of any Fund representatives from its premises in the event that their actions, in the reasonable opinion of the Transfer Agent, jeopardize the information security of its systems and/or other client data or otherwise are disruptive to the business of the Transfer Agent. The Transfer Agent may require any persons seeking access to its facilities to provide reasonable evidence of their authority. The Transfer Agent may also reasonably require any of the Fund’s representatives to execute a confidentiality agreement before granting such individuals access to its facilities. The Transfer Agent will also provide reasonable access to the Fund’s governmental regulators, at the Fund’s expense, solely to (i) the Fund’s records held by the Transfer Agent and (ii) the procedures of the Transfer Agent directly related to its provision of services to the Fund under the Agreement.

  • Clinical Studies The animal and other preclinical studies and clinical trials conducted by the Company or on behalf of the Company were, and, if still pending are, to the Company’s knowledge, being conducted in all material respects in compliance with all Applicable Laws and in accordance with experimental protocols, procedures and controls generally used by qualified experts in the preclinical study and clinical trials of new drugs and biologics as applied to comparable products to those being developed by the Company; the descriptions of the results of such preclinical studies and clinical trials contained in the Registration Statement and the Prospectus are accurate and complete in all material respects, and, except as set forth in the Registration Statement and the Prospectus, the Company has no knowledge of any other clinical trials or preclinical studies, the results of which reasonably call into question the clinical trial or preclinical study results described or referred to in the Registration Statement and the Prospectus when viewed in the context in which such results are described; and the Company has not received any written notices or correspondence from the FDA, the EMA, or any other domestic or foreign governmental agency requiring the termination, suspension or modification of any preclinical studies or clinical trials conducted by or on behalf of the Company that are described in the Registration Statement and the Prospectus or the results of which are referred to in the Registration Statement and the Prospectus.

Time is Money Join Law Insider Premium to draft better contracts faster.